It has been reported that the mutation of PTPN11 is associated with high prevalence of juvenile myelomonocytic leukemias, neuroblastoma, melanoma, acute myeloid leukemia, breast cancer, lung cancer, and colorectal cancer [33]. This evidence concerns the gene PTPN11 and lung carcinoma.